FR2598320B1 - Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques - Google Patents

Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques

Info

Publication number
FR2598320B1
FR2598320B1 FR868618075A FR8618075A FR2598320B1 FR 2598320 B1 FR2598320 B1 FR 2598320B1 FR 868618075 A FR868618075 A FR 868618075A FR 8618075 A FR8618075 A FR 8618075A FR 2598320 B1 FR2598320 B1 FR 2598320B1
Authority
FR
France
Prior art keywords
water
active ingredient
pharmaceutical compositions
compositions containing
therapeutic applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR868618075A
Other languages
English (en)
Other versions
FR2598320A1 (fr
Inventor
Pierre-Noel Brasey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seuref AG
Original Assignee
Seuref AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seuref AG filed Critical Seuref AG
Publication of FR2598320A1 publication Critical patent/FR2598320A1/fr
Application granted granted Critical
Publication of FR2598320B1 publication Critical patent/FR2598320B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FR868618075A 1985-12-24 1986-12-23 Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques Expired - Fee Related FR2598320B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH5525/85A CH667387A5 (it) 1985-12-24 1985-12-24 Formulazioni farmaceutiche acquose di ubichinone.

Publications (2)

Publication Number Publication Date
FR2598320A1 FR2598320A1 (fr) 1987-11-13
FR2598320B1 true FR2598320B1 (fr) 1990-11-02

Family

ID=4295081

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868618075A Expired - Fee Related FR2598320B1 (fr) 1985-12-24 1986-12-23 Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques

Country Status (7)

Country Link
JP (1) JPS62158209A (fr)
BE (1) BE906034A (fr)
CH (1) CH667387A5 (fr)
DE (1) DE3643330A1 (fr)
FR (1) FR2598320B1 (fr)
GB (1) GB2184355B (fr)
IT (1) IT1198247B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1250672B (it) * 1991-07-11 1995-04-21 Idb Holding Spa Formulazioni orali di ubidecarenone in soluzione acquosa
ES2051643B1 (es) * 1992-10-13 1995-02-16 Inverni Della Beffa Farma Formulaciones orales de ubidecarenona en forma de soluciones acuosas.
GR1001364B (el) * 1992-10-16 1993-10-29 Inverni Della Beffa Farma Από του στόματος συν?έσεις ουβιδεκαρενόνης υπό μορφήν υδατικών διαλυμάτων.
WO1998035658A2 (fr) * 1997-02-12 1998-08-20 Mse Pharmazeutika Gmbh Utilisation de 2,3-dimethoxy-5-methyle-6-decaprenyle-1,4-benzoquinone
ATE251454T1 (de) * 1997-02-12 2003-10-15 Mse Pharmazeutika Gmbh Verwendung von 2,3-dimethoxy-5-methyl-6- decaprenyl-1,4-benzochinon inder behandlung von tinnitus
WO2002076433A1 (fr) * 2001-03-27 2002-10-03 C.S. Bioscience, Inc. Preparation dentaire
US5925335A (en) * 1997-06-12 1999-07-20 C.S. Bioscience Inc. Dental formulation
EP0888774A3 (fr) * 1997-06-30 1999-11-10 Soft Gel Technologies, Inc. Formulation de gel contenant la coenzyme Q10
US6200550B1 (en) * 1998-12-11 2001-03-13 Q-Pharma, Inc. Oral care compositions comprising coenzyme Q10
DE19944137A1 (de) * 1999-09-15 2001-03-22 Beiersdorf Ag O/W-Emulsionen mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerin
JP3742602B2 (ja) * 2001-05-09 2006-02-08 株式会社カネカ 還元型補酵素ｑの安定な溶液
WO2005035477A1 (fr) * 2003-10-08 2005-04-21 Kaneka Corporation Procede pour stabiliser un compose presentant un squelette quinone et composition ainsi stabilisee
EP1811977B1 (fr) * 2004-11-16 2018-01-10 Bioavailability, Inc. Preparations autoemulsifiantes a concentration elevee a base de coenzyme q10 a usage nutritionnel
JP5999765B2 (ja) * 2012-12-07 2016-09-28 バイオアバイラビリティ，インク． 栄養学的に使用するための高濃度自己マイクロエマルジョン化コエンザイムｑ１０調製物
JP5722299B2 (ja) * 2012-12-07 2015-05-20 バイオアバイラビリティ，インク． 栄養学的に使用するための高濃度自己マイクロエマルジョン化コエンザイムｑ１０調製物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1334961A (fr) * 1961-03-06 1963-08-16 Merck & Co Inc Solutions aqueuses stables à base de benzoquinone substituée
NL275602A (fr) * 1961-03-06
JPS498246B1 (fr) * 1965-07-15 1974-02-25
GB1225979A (fr) * 1967-03-23 1971-03-24
GB1317865A (en) * 1971-11-15 1973-05-23 Jujo Paper Co Ltd Biologically active composition
JPS5218811A (en) * 1975-08-01 1977-02-12 Eisai Co Ltd Preparation of aqueous solution of fat- soluble substances
JPS58113127A (ja) * 1981-12-28 1983-07-05 Ajinomoto Co Inc ユビデカレノン含有水性液
JPS6025918A (ja) * 1983-07-25 1985-02-08 Ajinomoto Co Inc 脂溶性薬物含有水性液

Also Published As

Publication number Publication date
IT8622844A0 (it) 1986-12-23
BE906034A (fr) 1987-04-16
GB2184355A (en) 1987-06-24
JPS62158209A (ja) 1987-07-14
CH667387A5 (it) 1988-10-14
GB2184355B (en) 1990-03-28
IT1198247B (it) 1988-12-21
GB8630158D0 (en) 1987-01-28
JPH0455404B2 (fr) 1992-09-03
IT8622844A1 (it) 1988-06-23
FR2598320A1 (fr) 1987-11-13
DE3643330A1 (de) 1987-06-25

Similar Documents

Publication Publication Date Title
FR2602141B1 (fr) Composition pharmaceutique a activite analgesique contenant de l'ibuprofene comme principe actif
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
DE3686483D1 (de) Arzneimittel.
DE3669104D1 (de) Pharmazeutische praeparate, die ascorbinsaeurederivate enthalten.
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
BR9206632A (pt) Sistema de penetração na pele melhorado para melhorada liberação tópica de drogas
DE3679722D1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
MC2094A1 (fr) Medicament contenant de l'acide dihydrolipoique en tant que substance active,procede de preparation
DE3679920D1 (de) Spiro-3-heteroazolidinverbindungen und ihre salze, ihre herstellung und diese enthaltende pharmazeutische mittel.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
BE893193A (fr) Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif
FR2490491B1 (fr) Composition pharmaceutique analgesique contenant comme ingredient actif l'acide 3-amino-2-hydroxy-4 phenylbutanoique et ses derives et application
IT8521322A0 (it) Composti e composizioni farmaceutiche per la terapia di retinopatie e neuropatie diabetiche.
FR2581873B1 (fr) Preparations pharmaceutiques a activite anti-hypertensive et cardioprotectrice contenant du verapamil, du triamterene et de l'hydrochlorothiazide
IT1233198B (it) Derivati di benzilidene ciclanoni,procedimento per la loro preparazione, loro impiego come agenti anti- ossidanti, composizioni cosmetiche e farmaceutiche che li contengono
FR2641189B1 (fr) Compositions pharmaceutiques contenant de l'acide acetyl salicylique et de la vitamine b6
BE902055A (fr) Preparations pharmaceutiques.
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
FR2565586B1 (fr) Derives de la naphtoxazine, leur preparation, leur application comme medicaments et compositions pharmaceutiques les contenant
FR2567402B1 (fr) Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
LU81501A1 (fr) Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques
FR2607005B1 (fr) Compositions pharmaceutiques contenant de l'acide ursodesoxycholique
IT8221120A0 (it) Composizione farmaceutica per combattere l'aggregazione delle piastrine.
FR2567756B1 (fr) Nouvelles compositions pharmaceutiques contenant comme ingredient actif l'acetyl-10 triacetoxy-1,8,9 anthracene

Legal Events

Date Code Title Description
ST Notification of lapse